In 2023, the global Chronic Obstructive Pulmonary Disease (COPD) Market is anticipated to be worth US$ 21.58 billion. With rising alcohol use, the overall demand for Chronic Obstructive Pulmonary Disorder (COPD) is expected to rise at a CAGR of 4.4% between 2023 and 2033, reaching roughly US$ 33.19 billion by 2033. According to a study by the …
Monthly Archives: March 2023
Molecular Diagnostics Market is anticipated to reach a high of US$ 59882.97671 Million by 2032
Molecular diagnostics is a method of analyzing and identifying the biological markers in the genome and proteome in order to identify gene expression by applying molecular biology. Molecular diagnostics are used to diagnose disease and risk involved. Molecular Diagnostics helps to decide the therapies are suitable for individual patients. The projection term is expected to see a …
Proteomics Market is projected to grow at a robust CAGR of 13.5% by 2022 to 2032
In 2022, the global proteomics market size was estimated to be around US$ 30.8 Billion. Proteomics demand is anticipated to reach US$ 109.4 Billion by the end of 2032, growing at a strong CAGR of 13.5% between 2022 and 2032. The proteomics market has grown substantially at a healthy CAGR due to growing need for personalized medicine and …
Continue reading “Proteomics Market is projected to grow at a robust CAGR of 13.5% by 2022 to 2032”
Breast Cancer Drug Market is projected to grow at a CAGR of 1.1% by 2022 to 2032,
The global breast cancer drugs market is anticipated to reach a valuation of US$ 11,750.33 Mn by 2032, with sales growing at a stagnant CAGR of 1.1% from 2022 to 2032. The target market is expected to reach a value of US$ 10,637.42 Mn in 2022. The rising incidences of breast cancer, introduction of new therapies, and …
Continue reading “Breast Cancer Drug Market is projected to grow at a CAGR of 1.1% by 2022 to 2032,”
Hand Eczema (HE) Treatment Market is expected to garner a market value of US$ 53 Million in 2023
The global Hand Eczema (HE) Treatment Market is expected to garner a market value of US$ 53 Million in 2023 and is expected to accumulate a market value of US$ 114.42 Million by registering a CAGR of 8% in the forecast period 2023 to 2033. The market for Hand Eczema (HE) Treatment registered a CAGR of 4% in the historical period 2018 to 2022. According …
Biodefense Market size was valued at US$ 16.31 billion in the year 2023
It is estimated that the market is anticipated to reach US$ 32.99 billion by 2033 after being valued at US$ 16.31 billion in 2023. This market is projected to expand at a CAGR of 7.3% during the analysis period. The growing demand for vaccines, drugs, and medical devices provides companies with opportunities to expand their …
Continue reading “Biodefense Market size was valued at US$ 16.31 billion in the year 2023”
Intratumoral Cancer Therapies Market by registering a CAGR of 10% in the forecast period 2023 to 2033
A recently published study by FMI expects the global Intratumoral Cancer Therapies market to garner a market value of US$ 212.96 Billion in 2023 and is expected to accumulate a market value of US$ 552.36 Billion by registering a CAGR of10% in the forecast period 2023-2033. Growth of the Intratumoral Cancer Therapies market can be attributed to favorable regulatory frameworks for cancer …
IgA Nephropathy Market by registering a CAGR of 7.5% in the forecast period 2023 to 2033
During the forecast period 2023 to 2033, the IgA nephropathy market is expected to grow at a value of 7.5% CAGR, according to Future Market Insights. By the year 2033, the global market for IgA nephropathy is expected to rise up to a market valuation of US$ 85 Billion. Key factors such as high prevalence of kidney …
Combined Sales of Anti-biofilm Wound Dressing is expected to reach US$ 1939.45 million by 2033
The net worth of the market share of the anti-biofilm wound dressing is predicted to reach from US$ 782.60 million in 2023 to over US$ 1939.45 million by 2033, recording a CAGR of 9.5% between 2023 and 2033. Incidence rates for chronic and acute wounds are expected to increase which is, driving demand for anti-biofilm wound dressings. Besides antimicrobial resistance and …
Head and Neck Cancer (HNC) Therapeutics market is forecast to reach US$ 5.19 Billion by 2033
The global Head and Neck Cancer (HNC) Therapeutics market is anticipated to surpass a remarkable worth of US$ 1.58 Billion in 2023, with a compound annual growth rate (CAGR) of 12.6% from 2023 to 2033. Developments in the detection and treatment of head and neck cancer (HNC) are expected to propel market expansion as they are less …